In 2024, the U.S. recorded a historic decline in drug overdose deaths, with an estimated decrease of 30,000 from 2023, resulting in 80,000 total deaths. This 27% drop marks the largest one-year decrease in the history of CDC tracking. However, overdose deaths are still higher than pre-pandemic levels, especially among those aged 18-44. Experts express concerns that this positive trend may reverse due to potential funding cuts and changes in public health strategies. Contributing factors to the decrease include greater naloxone accessibility, expanded treatment options, and shifts in drug use patterns.
The largest one-year decline in U.S. drug overdose deaths was seen in 2024, with an overall decrease of 30,000 deaths compared to the previous year.
Despite a significant drop in overdose deaths, the CDC emphasizes that overdose remains the leading cause of death for adults 18-44, indicating the necessity for continued intervention.
Experts caution that the progress made in reducing overdose deaths may be threatened by reductions in funding and a potential shift in strategies that are proving effective.
Factors contributing to the decline include increased availability of naloxone, expanded addiction treatment, and a reduction in the number of at-risk individuals.
Collection
[
|
...
]